vimarsana.com

Page 4 - பாதுகாப்பு நிறுவனம் ஆஃப் உடலியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus | DRDO develops antibody detection kit

Coronavirus | DRDO develops antibody detection kit Updated: Updated: Commercial launch of product in June first week Share Article Commercial launch of product in June first week The Defence Research and Development Organisation (DRDO) on Friday said it had, in collaboration with a company, developed an antibody detection kit for spotting SARS-CoV-2 virus with a high sensitivity of 97% and specificity of 99%. “The DIPCOVAN kit was developed indigenously by the scientists, followed by extensive validation on more than 1,000 patient samples at various COVID designated hospitals in Delhi. Three batches of the product were validated during last one year. The antibody detection kit is approved by Indian Council of Medical Research (ICMR) in April 2021,” it said in a statement.

DRDO Scientists Develop Indigenous COVID Antibody Detection Kit DIPCOVAN , To Be Launched Early Next Month

DRDO Scientists Develop Indigenous COVID Antibody Detection Kit DIPCOVAN , To Be Launched Early Next Month Covid-19 antibody detection kit DIPCOVAN (PIB) Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation (DRDO), has developed an antibody detection-based kit DIPCOVAN . The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent. The kit has been developed in association with Vanguard Diagnostics Pvt Ltd, a development and manufacturing diagnostics company based at New Delhi. The DIPCOVAN kit was developed indigenously by the scientists, followed by extensive validation on more than 1,000 patient samples at various Covid designated hospitals in Delhi.

DRDO develops COVID-19 antibody detection kit DIPCOVAN

DRDO develops COVID-19 antibody detection kit DIPCOVAN This kit has been developed for the qualitative detection of IgG antibodies in human serum or plasma, targeting the antigens related to COVID-19 causing SARS-CoV-2 virus BusinessToday.In | May 21, 2021 | Updated 19:35 IST DIPCOVAN has been developed by DRDO scientists in collaboration with Delhi-based Vanguard Diagnostics Pvt Ltd Defence Institute of Physiology and Allied Sciences (DIPAS), the research laboratory of Defence Research and Development Organisation (DRDO), has developed an antibody detection-based kit called DIPCOVAN . The kit will help people detect if they have previously been exposed to the COVID-19 virus and if their bodies had produced antibodies to combat it.  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.